Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Sells $145,840.50 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Jamie Samath also recently made the following trade(s):

• On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.00, for a total value of $101,332.00.
• On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The stock was sold at an average price of $542.06, for a total value of $58,542.48.
• On Friday, November 8th, Jamie Samath sold 22,903 shares of Intuitive Surgical stock. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00.
• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $539.58 on Friday. Intuitive Surgical, Inc. has a 1-year low of $320.26 and a 1-year high of $556.23. The company has a market capitalization of $192.19 billion, a price-to-earnings ratio of 86.75, a PEG ratio of 5.35 and a beta of 1.38. The business has a 50-day moving average of $521.82 and a 200-day moving average of $478.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently added to or reduced their stakes in ISRG. Mirador Capital Partners LP boosted its position in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares during the last quarter. Consolidated Planning Corp boosted its holdings in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Intuitive Surgical by 617.1% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after purchasing an additional 76,649 shares during the last quarter. Swiss National Bank grew its stake in Intuitive Surgical by 0.3% during the 3rd quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after purchasing an additional 3,400 shares in the last quarter. Finally, Zacks Investment Management increased its holdings in Intuitive Surgical by 3.2% during the 3rd quarter. Zacks Investment Management now owns 30,196 shares of the medical equipment provider’s stock worth $14,834,000 after purchasing an additional 928 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ISRG has been the subject of several recent analyst reports. Leerink Partners lifted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Raymond James increased their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, BTIG Research increased their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $550.28.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.